Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Viatris Inc. - Common Stock
(NQ:
VTRS
)
10.69
+0.05 (+0.47%)
Streaming Delayed Price
Updated: 1:00 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viatris Inc. - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
20
21
Next >
Novo Nordisk Weight Loss Drug Patent Battle Against Viatris - Emerges As Winner
↗
October 03, 2023
Novo Nordisk A/S (NYSE: NVO) successfully defended two pivotal patent claims linked to the main ingredient in its popular weight-loss and diabetes drugs,
Via
Benzinga
Topics
Intellectual Property
Viatris Stock Bounds Higher As Divestitures Reach Nearly $7 Billion
↗
October 02, 2023
The company is retaining the rights to specific over-the-counter drugs in some markets.
Via
Investor's Business Daily
Viatris Phase 1 Asset Divestiture Story: Plans To Sell Certain OTC Products, Women's Healthcare Business & More
↗
October 02, 2023
Viatris Inc (NASDAQ: VTRS) disclosed multiple deals to sell remaining assets to conclude Phase 1 of planned asset disposition by
Via
Benzinga
Could Viatris Stock Help You Become a Millionaire?
↗
September 30, 2023
Viatris' broad portfolio gives the business lots of stability and plenty of opportunities -- but is there enough there for the stock to be a great long-term investment?
Via
The Motley Fool
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
↗
September 27, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Viatris Stock: Bear vs. Bull
↗
August 31, 2023
This is a case where both sides have compelling arguments.
Via
The Motley Fool
Better High-Yield Dividend Stock: Takeda Pharmaceutical vs. Viatris
↗
August 24, 2023
Via
The Motley Fool
Where Will Viatris Be in 5 Years?
↗
August 18, 2023
Can this become a good growth business to invest in?
Via
The Motley Fool
2 Beaten-Down Dividend Stocks to Buy
↗
August 11, 2023
These two stocks look like bargains right now for income investors.
Via
The Motley Fool
Despite Efforts, Vulnerable Patients Still Face Barriers to Essential Medicines, Says New Report
↗
September 26, 2023
Despite significant initiatives by generic drug companies to broaden access to vital medicines, many vulnerable patients remain underserved, according to findings from a new study from the Access to...
Via
Benzinga
NASDAQ: VTRS Shareholder Notice Investigation over Potential Wrongdoing by Certain Directors of Viatris Inc.
↗
September 22, 2023
San Diego, CA -- (SBWIRE) -- 09/22/2023 -- Certain directors of Viatris Inc.are under investigation concerning potential breaches of fiduciary duties.
Via
SBWire
'Stocks In Monopolistic Bull Market': Wall Street Analyst Contemplates A Bright Future For Next Phase
↗
September 22, 2023
The analyst illustrated how the dominant force in stock market returns for 2023 has been the "Magnificent 7."
Via
Benzinga
Want to Collect $500 in Dividends Every Month? Invest $90,000 in These 3 Stocks
↗
September 14, 2023
These stocks offer some mouth-watering payouts.
Via
The Motley Fool
Is Viatris Stock Good for Dividend Income?
↗
August 09, 2023
If you keep your expectations in check, it could be a great pick.
Via
The Motley Fool
A Preview Of Viatris's Earnings
↗
August 04, 2023
Via
Benzinga
Viatris Stock: Bull vs. Bear
↗
July 22, 2023
Viatris shares have declined in the double digits over the past few years.
Via
The Motley Fool
Daily Stock Analysis: Viatris
↗
July 20, 2023
Viatris Inc’s most recent $0.12 quarterly dividend, paid June 16th to shareholders of record May 23rd, equates to $0.48 annually to throw a yield of 4.58%.
Via
Talk Markets
3 Pharmaceutical Stocks That Are Too Cheap to Ignore
↗
September 09, 2023
Viatris, GSK, and Organon are all trading at less than 7 times earnings.
Via
The Motley Fool
CVS Health Just Created a New Problem For Viatris. Here's What You Need to Know
↗
September 01, 2023
CVS just fired a shot across Viatris' bow.
Via
The Motley Fool
VIATRIS ALERT: Bragar Eagel & Squire, P.C. is Investigating Viatris Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 22, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
Viatris Could Soon Make a Generic Ozempic, But Does That Make It a Buy?
↗
August 16, 2023
There are a few complicating factors that mean the generic form of the drug might not be a slam dunk.
Via
The Motley Fool
If You'd Invested $25,000 in Viatris in 2020, This Is How Much You Would Have Today
↗
August 11, 2023
Would you have been better off investing in the S&P 500?
Via
The Motley Fool
Topics
Stocks
Better Pharma Buy: Viatris vs. Pfizer
↗
July 19, 2023
Both stocks look cheap today.
Via
The Motley Fool
Better High-Yield Dividend Stock: Altria or Viatris?
↗
July 15, 2023
Which of these top income stocks is the better buy right now?
Via
The Motley Fool
Viatris Q2 Earnings Beat Estimates, Multiple Sclerosis Therapy Accepted For FDA Review
↗
August 07, 2023
Viatris Inc (NASDAQ: VTRS) reported Q2 FY23 sales of $3.91 billion, up 2% on a divestiture-adjusted operational basis, marginally higher the
Via
Benzinga
Elanco Animal Health, Sovos Brands, Veritiv, Graham And Other Big Stocks Moving Higher On Monday
↗
August 07, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 300 points on Monday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Want $1,500 in Annual Passive Income? Invest This Much in Viatris Stock Each Month for 5 Years
↗
August 04, 2023
If you're patient and consistent, it won't be too hard to build up a revenue stream.
Via
The Motley Fool
1 Reason I Wouldn't Buy This High-Yielding Dividend Stock
↗
July 20, 2023
Unless you're only in it for the dividend, you might be disappointed with this stock.
Via
The Motley Fool
A Look Into Healthcare Sector Value Stocks
↗
July 17, 2023
Via
Benzinga
VTRS DEADLINE TODAY: ROSEN, A TOP RANKED LAW FIRM, Encourages Viatris Inc. Investors with Losses to Secure Counsel Before Important July 14 Deadline in Securities Class Action - VTRS
July 14, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
20
21
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
